HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yaqi Duan Selected Research

Large Cell Carcinoma

1/2022SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yaqi Duan Research Topics

Disease

13Neoplasms (Cancer)
09/2023 - 01/2016
3Insulinoma
01/2022 - 01/2022
3COVID-19
01/2022 - 11/2020
3Myocardial Infarction
12/2017 - 11/2015
2Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 10/2016
1Large Cell Carcinoma
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Breast Neoplasms (Breast Cancer)
12/2021
1Triple Negative Breast Neoplasms
10/2021
1Inflammation (Inflammations)
12/2020
1Fibrosis (Cirrhosis)
12/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020
1Atherosclerosis
01/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020
1Adenocarcinoma of Lung
01/2019
1Carcinogenesis
01/2018
1Seizures (Absence Seizure)
04/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2016
1Hemangiosarcoma (Angiosarcoma)
01/2016
1Capillary Hemangioma
01/2016
1Hypoxia (Hypoxemia)
09/2010
1Necrosis
07/2010
1Heart Failure
10/2006

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
3MicroRNAs (MicroRNA)IBA
01/2018 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2022 - 10/2016
2Messenger RNA (mRNA)IBA
01/2022 - 01/2016
2Cyclin D1IBA
10/2018 - 01/2016
2Stem Cell FactorIBA
12/2017 - 01/2016
1Anaplastic Lymphoma KinaseIBA
09/2023
1Keratins (Keratin)IBA
09/2023
1DesminIBA
09/2023
1MyogeninIBA
09/2023
1SynaptophysinIBA
01/2022
1Chromogranin AIBA
01/2022
1venetoclaxIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1AntigensIBA
01/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2022
1Circulating Tumor DNAIBA
01/2022
1Annexin A5IBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1CarbohydratesIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1CytokinesIBA
01/2022
12- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA
01/2022
1Semaphorins (Semaphorin)IBA
12/2021
1ImmunosorbentsIBA
12/2021
1EnzymesIBA
12/2021
1CD3 ComplexIBA
10/2021
1FibrinIBA
12/2020
1Peptide Hydrolases (Proteases)FDA Link
11/2020
1CathepsinsIBA
11/2020
1fasudil (AT 877)IBA
01/2020
1CXC ChemokinesIBA
01/2020
1rho-Associated KinasesIBA
01/2020
1MTOR InhibitorsIBA
11/2019
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
01/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2019
1Lactic Acid (Lactate)FDA LinkGeneric
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1CateninsIBA
10/2018
14,6- dimorpholino- N- (4- nitrophenyl)- 1,3,5- triazin- 2- amineIBA
07/2017
1LigandsIBA
07/2017
1Anticonvulsants (Antiepileptic Drugs)IBA
04/2017
1Formaldehyde (Formol)FDA Link
11/2016
1ParaffinIBA
11/2016
1ErbB Receptors (EGF Receptor)IBA
11/2016
1TRAM 34IBA
01/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1Metalloproteases (Metalloproteinases)IBA
01/2016
1Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA
01/2016
1ChemokinesIBA
11/2015
1Chemokine CXCL12IBA
11/2015
1CXCR ReceptorsIBA
09/2010
1myocardinIBA
09/2010
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2010
1Eosine Yellowish-(YS) (Eosin)IBA
07/2010
1Hematoxylin (Haematoxylon)IBA
07/2010

Therapy/Procedure

3Therapeutics
01/2022 - 10/2016
1Modified Radical Mastectomy (Mastectomy, Modified)
12/2021
1Drug Therapy (Chemotherapy)
10/2021
1Cardiomyoplasty
10/2006